National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1254975



Case Details

VAERS ID: 1254975 (history)  
Form: Version 2.0  
Age: 0.5  
Sex: Unknown  
Location: Texas  
Vaccinated:2021-03-22
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8727 / 2 - / OT

Administered by: Private       Purchased by: ?
Symptoms: Exposure via breast milk, Fever neonatal, Illness, Rash
SMQs:, Anaphylactic reaction (broad), Neonatal exposures via breast milk (narrow), Neonatal disorders (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021387935

Write-up: my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; This is a spontaneous report received from a contactable other healthcare professional. This reporter reported information for both mother and fetus/baby. This is the baby report. Only this case is serious. A 6-months-old patient of an unspecified gender received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via other routed of administration on 22Mar2021 10:00 (Batch/Lot Number: ER8727) as single dose for covid-19 immunisation. Patient received the first dose on 01Mar2021 10:00 with lot number EN6202. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient''s mother reported that separately, her 6 month old, whom she was breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later. Outcome of events was unknown. No follow-up attempts are needed. No further information is expected; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021387880 same reporter/drug, different patient/event(mother case)


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1254975


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166